Genix Pharmaceuticals Corporation
GENPF
$0.0138
-$0.0262-65.50%
OTC PK
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.40K | 3.10K | 2.20K | 8.20K | 7.40K |
Total Receivables | 700.00 | 2.00K | 4.90K | 4.20K | 3.60K |
Inventory | -- | -- | -- | -- | 115.80K |
Prepaid Expenses | 11.30K | 20.60K | 27.50K | 15.40K | 36.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 15.30K | 25.70K | 34.50K | 27.80K | 163.40K |
|
|||||
Total Current Assets | 15.30K | 25.70K | 34.50K | 27.80K | 163.40K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 4.30K | 4.50K | 4.50K | 4.90K | 5.10K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 19.60K | 30.20K | 39.00K | 32.70K | 168.50K |
|
|||||
Total Accounts Payable | 125.00K | 121.10K | 118.90K | 107.30K | 191.00K |
Total Accrued Expenses | 10.80K | 7.20K | 9.00K | 14.40K | 10.90K |
Short-term Debt | 739.10K | 698.40K | 627.60K | 585.30K | 535.20K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 175.10K | 174.90K | 175.10K | 174.80K | 419.30K |
Total Other Current Liabilities | 175.10K | 174.90K | 175.10K | 174.80K | 419.30K |
Total Current Liabilities | 1.05M | 1.00M | 930.70K | 881.80K | 1.16M |
|
|||||
Total Current Liabilities | 1.05M | 1.00M | 930.70K | 881.80K | 1.16M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 739.10K | 698.40K | 627.60K | 585.30K | 535.20K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.05M | 1.00M | 930.70K | 881.80K | 1.16M |
|
|||||
Common Stock & APIC | 7.01M | 7.02M | 6.70M | 6.96M | 7.02M |
Retained Earnings | -8.99M | -8.95M | -8.51M | -8.76M | -8.95M |
Treasury Stock & Other | 953.70K | 955.20K | 912.00K | 947.20K | 935.80K |
Total Common Equity | -1.03M | -971.50K | -891.60K | -849.10K | -987.80K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.03M | -971.50K | -891.60K | -849.10K | -987.80K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.03M | -971.50K | -891.60K | -849.10K | -987.80K |
|